On January 31, 2023, the CDC and local and state health departments across 12 states uncovered 55 cases of patients who had a rare strain of bacterial infection stemming from Pseudomonas aeruginosa. This bacteria can cause severe complications, such as permanent vision loss and even death if untreated or improperly diagnosed.
Due to this revelation, Global Pharma Healthcare recalled both the EzriCare and Delsam eye drops on February 2, 2023.
